VANESSA ZACROISKY: Open Payments
NPI 1891491213 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 43 payments from 15 companies in 2025. Trend: 2023 $97 · 2024 $173 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| ABBVIE INC. | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $110 |
| Lilly USA, LLC | 6 | $94 |
| PFIZER INC. | 4 | $85 |
| Novo Nordisk Inc | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| Exact Sciences Corporation | 2 | $48 |
| Eisai Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
Products named: LEQVIO, Kerendia, VRAYLAR, KISUNLA, Cologuard Collection Kit, OTEZLA, MOUNJARO, NURTEC ODT.
Industry payments across FL — which companies pay providers there.
